Philips Respironics introduced Patient Adherence Management Service (PAMS) at the SLEEP 2016 conference; PAMS will support new patients’ transition to sleep therapy.

PAMS utilizes Philips Respironics’ EncoreAnywhere software, DreamStation PAP therapy devices, Philips’ portfolio of masks, and the DreamMapper patient engagement application. PAMS is a concrete example of how Philips’ connected care management solutions help provide customers with insight and the necessary tools to enhance overall patient care.

“For years, Philips Respironics has provided innovative solutions to help patients with sleep and breathing disorders, always leveraging technology to make therapy feel as natural as possible,” says Mark Aloia, PhD, vice president and global lead, behavior change at Philips, in a release. “Our innovations are connected to intuitively work together at every phase of the health continuum and are designed to enable exceptional outcomes in patient adherence. With this new connected management service, our goal is to help patients fully engage with and adapt to their therapy, ultimately helping them live healthier lives.”

Developed as a result of input from homecare providers looking for additional support to improve sleep patient adherence, PAMS has been shown to boost adherence rates of CPAP patients by an average of 49%.* PAMS leverages Philips’ knowledge of sleep apnea and the data of millions of patients who have been managed by EncoreAnywhere.

PAMS has shown to improve adherence rates up to 24% within the first 90 days, and at least 16% or more in the first 30 days of therapy.** PAMS aims to not only help improve compliance rates, but improve the experience of new patients attempting to adapt to therapy. Key components of the PAMS program, include:

  • Patient outreach protocol: This includes personalized calls, e-mails, and texts to deliver education, motivational reminders, and support from sleep coaches and respiratory therapists trained in health behavior change;
  • EncoreAnywhere software and predictive modeling: PAMS uses this software for workflow and communications with homecare providers, helping to identify patients struggling with therapy adoption and personalize coaching;
  • Dream Family Connectivity: PAMS uses the DreamStation PAP device (connected via cell or WiFi), Philips’ masks, and the DreamMapper patient engagement app.

PAMS is the latest in applied-data solutions from Philips that build on the company’s commitment to creating solutions that help better manage sleep and respiratory conditions and improve patient care. Philips’ track record in providing connected solutions can be seen in additional technologies that were on-site during SLEEP 2016, including the Care Orchestrator care management application. Care Orchestrator allows patients to stay connected to their care teams throughout the course of therapy. It is the next generation of EncoreAnywhere, and enables data, clinical management workflow, informatics, and intelligence for providers, payors, and patients within a single cloud-based platform. A full range of Philips sleep and respiratory devices, including DreamStation BiPAP ASV and BiPAP AVAPS, Trilogy, EverFlo, SimplyGo and iNeb, are planned to connect to Care Orchestrator and tie into the Philips HealthSuite cloud platform.

*Retrospective study using 2014 -2016 EncoreAnywhere data from 12 Home Care Providers that used PAMS for at least six months. CMS Compliance definition – minimum of 4 hours of use over 70% of the nights during a consecutive 30 day period within the first 90 days of use.

**Retrospective study using 2014 -2016 EncoreAnywhere data from 12 Home Care Providers that used PAMS for at least six months. CMS Compliance definition – minimum of 4 hours of use over 70% of the nights during a consecutive 30 day period within the first 90 days of use.